Sonosine Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 5

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $312K

  • Investors
  • 5

Sonosine General Information


Developer of a core medical imaging technology designed to change the way clinicians diagnose and treat patients in primary care settings. The company's technology improves clinical decision-making by using a patented EMA imaging technology that makes quality medical diagnostics quick, safe, and comfortable for patients, enabling clinicians to get reliable images that enable informed and efficient decision-making.

Contact Information

Formerly Known As
Oxford Enhanced Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Centre for Innovation and Enterprise, Begbroke Science Park
  • Begbroke Hill, Woodstock Road
  • Begbroke OX5 1PF
  • England, United Kingdom
+44 01865 000000

Sonosine Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sonosine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 30-Oct-2020 $312K 00.000 00.000 Completed Generating Revenue
3. Seed Round 04-Jun-2019 00.000 00.000 00.000 Completed Startup
2. Seed Round 15-May-2018 $515K $1.51M 00.000 Completed Startup
1. Seed Round 07-Oct-2015 $1M $1M 00.000 Completed Startup
To view Sonosine’s complete valuation and funding history, request access »

Sonosine Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
To view Sonosine’s complete cap table history, request access »

Sonosine Executive Team (3)

Name Title Board Seat Contact Info
David Herbada Chief Executive Officer & Board Member
David Edwards Ph.D Founder & Chief Technology Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Sonosine Board Members (5)

Name Representing Role Since
David Herbada Sonosine Chief Executive Officer & Board Member 000 0000
Jian Cao Self Board Member 000 0000
Mark Prendergast Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Sonosine Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sonosine Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Technikos Venture Capital Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
Oxford Science Enterprises University Minority 000 0000 000000 0
Oxford University Innovation University Minority 000 0000 000000 0
Yongping Zhang Angel (individual) Minority 000 0000 000000 0
To view Sonosine’s complete investors history, request access »